Skip to content
The Intraday
Pulse TodayMorning BriefMid-Morning BriefMorning ReportNewsletter OpsMarket OverviewPre-MarketChartFundamentalsOverviewMarket InternalsFinancialsInternationalInsiders

Cohen & Steers, Inc.

CNS
$84.22
+$0.13 (0.15%)+0.15%
Closed
Loading chart...
IndexN/A
Market Cap4.33B
Enterprise Value3.21B
Income$0.14B
Sales$0.57B
EmployeesN/A
P/E26.82
P/S5.67
P/B5.72
P/C-25.45
EV/EBITDA16.01
EV/SalesN/A
EPS (ttm)3.14
EarningsN/A
Gross Margin57.51%
Oper. Margin31.30%
Profit Margin26.98%
Volume0.16M
Shs Outstand0.05B
Change0.15%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Revenue$567.80M$517.42M$489.64M$573.72M$583.83M$430.90M$410.83M$391.54M
Cost of Revenue$241.28M$275.12M$254.35M$291.76M$271.33M$271.54M$198.67M$181.34M
Gross Profit$326.52M$242.30M$235.29M$281.96M$312.50M$159.36M$212.16M$210.20M
Gross Margin57.51%46.83%48.05%49.15%53.53%36.98%51.64%53.69%
Operating Expenses$148.78M$69.42M$70.81M$66.03M$52.13M$64.30M$52.03M$63.16M
Operating Income$177.74M$172.88M$164.48M$215.94M$260.37M$95.06M$160.13M$147.04M
Operating Margin31.30%33.41%33.59%37.64%44.60%22.06%38.98%37.55%
Net Income$144.87M$151.26M$129.05M$171.04M$211.40M$76.58M$134.62M$113.90M
Net Margin25.51%29.23%26.36%29.81%36.21%17.77%32.77%29.09%
EPS (Basic)$2.99$3.00$2.62$3.51$4.38$1.60$2.85$2.43
EBITDAN/AN/AN/AN/AN/AN/AN/AN/A
Stock Option Compensation ExpenseN/AN/AN/AN/AN/AN/AN/AN/A
Price To Earnings RatioN/AN/AN/AN/AN/AN/AN/AN/A
Price To Sales RatioN/AN/AN/AN/AN/AN/AN/AN/A
Shares OutstandingN/AN/AN/AN/AN/AN/AN/AN/A
Market CapitalizationN/AN/AN/AN/AN/AN/AN/AN/A

Company coverage

Latest news

20 stories
Jul 31 · 8:30AMCerenome Launches as an Integrated CNS Oncology Companyglobenewswire.com ↗Jul 30 · 4:17PMCohen & Steers, Inc. Declares Quarterly Dividendprnewswire.com ↗Jul 30 · 12:41PMAMG or CNS: Which Is the Better Value Stock Right Now?zacks.com ↗Jul 29 · 4:05PMCohen & Steers Closed-end Opportunity Fund, Inc. Issues Important Notice Regarding Change in Investment Policy and Investment Strategyprnewswire.com ↗Jul 28 · 5:47PMCohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)prnewswire.com ↗Jul 28 · 5:36PMCohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)prnewswire.com ↗Jul 28 · 5:20PMCohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)prnewswire.com ↗Jul 28 · 5:04PMCohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)prnewswire.com ↗
Show 12 more stories↓
Jul 28 · 4:55PMCohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)prnewswire.com ↗Jul 28 · 7:30AMPlus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conferenceglobenewswire.com ↗Jul 27 · 3:56AMGabelli Funds LLC Has $11.91 Million Position in Cohen & Steers Inc $CNSdefenseworld.net ↗Jul 23 · 9:00PMHarbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growthgurufocus.com ↗Jul 21 · 7:30AMPlus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancerglobenewswire.com ↗Jul 20 · 9:00AMCohen & Steers Appoints Erik Schneberger as Chief Marketing Officerprnewswire.com ↗Jul 17 · 1:31PMCohen & Steers Q2: Rally Reflects Improving Real Estate Flows (Downgrade)seekingalpha.com ↗Jul 17 · 1:16PMCohen & Steers, Inc. (CNS) Q2 2026 Earnings Call Transcriptseekingalpha.com ↗Jul 17 · 11:04AMCohen & Steers Q2 Earnings Call Highlightsmarketbeat.com ↗Jul 16 · 4:34PMCOHEN & STEERS REPORTS RESULTS FOR SECOND QUARTER 2026prnewswire.com ↗Jul 16 · 9:00AMCohen & Steers Quality Income Realty Fund, Inc. Announces Preliminary Results of Transferable Rights Offeringprnewswire.com ↗Jul 14 · 7:30AMPlus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoringglobenewswire.com ↗

Insider Trading

View All
Insider
Type
Shares
Price
Value
Date
Dulik Elena
Sell
1.1K
$83.16
$91K
Jul 20, 26
Villani Edmond D
Gift
472
—
—
Jul 6, 26
COHEN MARTIN
Award
353
—
—
Jul 1, 26
Smith Dasha
Award
353
—
—
Jul 1, 26
THISSEN KAREN WILSON
Award
353
—
—
Jul 1, 26

Company

CEO: Joseph Martin HarveyEmployees: 424www.cohenandsteers.com
About the company↓

Cohen & Steers, Inc. operates as a publicly traded holding company specializing in asset management. Through its various operating units, the firm delivers financial services to institutional investors, such as pension funds, university endowments, and charitable foundations. Its subsidiaries are tasked with managing bespoke client portfolios across equities, fixed income, multi-asset strategies, and commodities. Additionally, these subsidiaries develop and oversee a diverse range of investment vehicles, including mutual funds (focused on equity, fixed income, balanced, and multi-asset classes) and hedge funds. The company's global investment strategy, implemented via its affiliated entities, involves allocating capital in public equity, fixed income, and commodity markets. For its equity and fixed income allocations, the firm's affiliates specifically target businesses within the real estate industry (including REITs), infrastructure, and natural energy resources. Preferred securities also constitute a part of its fixed income portfolios. Established in 1986, Cohen & Steers, Inc. maintains its primary base in New York, with international branch offices in London (UK), Central (Hong Kong), Tokyo (Japan), and Seattle (Washington).

Discover more

You may be interested in
NVDA

NVIDIA Corp

$219.22

↑ 3.43%
CRM

Salesforce Inc

$192.98

↑ 1.04%
PYPL

PayPal Holdings Inc

$57.93

↓ 1.04%
BAC

Bank of America Corp

$63.25

↑ 0.56%
DIS

Walt Disney Co

$101.74

↑ 3.63%
GOOGL

Alphabet Inc

$362.43

↓ 4.03%
IBM

IBM Corp

$235.92

↑ 0.33%
AMD

Advanced Micro Devices

$482.05

↓ 7.04%
INTC

Intel Corp

$101.06

↑ 0.20%
MA

Mastercard Inc

$570.48

↓ 0.11%
ADBE

Adobe Inc

$259.32

↑ 0.71%
JPM

JPMorgan Chase & Co

$359.24

↑ 0.48%
The Intraday

© 2026 The Intraday. All rights reserved.

Market data may be delayedFor informational purposes onlyFMP · Massive · SEC